Internal Medicine, Pulmonary Disease · Bronx, NY
NPI
1053794321
Since 2015
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
111 E 210th St
Bronx, NY, 10467
Phone (718) 920-4231
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$543K
794 prescriptions
Company payments, 2025
$19.41
From 1 companies
Medicare prescription drug claims, 2024
In 2024, the drug Daniel Howell prescribed most often to Medicare patients was Dulera (Mometasone/Formoterol), with 166 prescriptions and refills. In total Daniel Howell wrote 794 Medicare prescriptions that cost $543K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-02-09.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Dulera Mometasone/Formoterol | 166 | 189 | 48 | $61K |
| Fluticasone Propionate Generic | 112 | 120 | 30 | $735 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 85 | 92 | 31 | $2,625 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 52 | 72 | 11 | $31K |
| Incruse Ellipta Umeclidinium Bromide | 44 | 54 | Under 11 | $18K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 35 | 44 | Under 11 | $27K |
| Dupixent Pen Dupilumab | 24 | 24 | Under 11 | $85K |
| Montelukast Sodium Generic | 24 | 48 | Under 11 | $152 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 22 | 22 | Under 11 | $13K |
| Symbicort Budesonide/Formoterol Fumarate | 22 | 22 | 13 | $4,472 |
| Fasenra Pen Benralizumab | 20 | 37 | Under 11 | $113K |
| Bevespi Aerosphere Glycopyrrolate/Formoterol Fum | 17 | 19 | Under 11 | $7,691 |
| Breo Ellipta Fluticasone/Vilanterol | 16 | 30 | Under 11 | $11K |
| Spiriva Respimat Tiotropium Bromide | 14 | 24 | Under 11 | $12K |
| Fasenra Benralizumab | 13 | 21 | Under 11 | $75K |
Brand drugs: 551 claims; generic drugs: 243 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel Howell $19.41 ($19.41 in general payments such as food, travel and fees) from 1 company. The largest payer was GlaxoSmithKline, LLC. with $19.41.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 1 | $19.41 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.